In normal circumstances, two components of bone remodeling, i.e. bone formation and bone resorption, are tightly coupled, so that total bone mass can be maintained. In osteoporosis, these two processes of bone remodeling are uncoupled and the rate of bone resorption exceeds that of bone formation. Although the pathogenesis of osteoporosis is not fully understood, multiple fac tors have been shown to participate in the develop ment of the disease. These include reduction in sex steroid hormone and calcitonin levels in post menopausal women (1) , a decrease in the renal synthesis as well as the serum levels of 1, 25-dihy droxyvitamin D [1,25(OH)2D] (2, 3) and a resultant reduction in intestinal calcium (Ca) absorption (3, 4). As a consequence, there is a negative mineral balance, both at the level of bone and of total body. Therefore, the ideal treatment of osteo porosis would not only be to reduce bone resorp tion, but also to increase bone formation and to m aintain positive mineral balance. In an effort to achieve this therapeutic goal, a rat model of post menopausal osteoporosis was introduced and the effects of various hormones on bone mineral me tabolism were examined.
Rat model of postmenopausal osteoporosis
As mentioned earlier, there is a reduction in serum estrogen level and intestinal Ca absorption in patients with postmenopausal osteoporosis. In order to simulate these conditions, 4-week-old fe male Sprague-Dawley rats were ovariectomized (OVX) and fed a low Ca diet containing 0.003% Ca and 0.3% phosphorus (P) for two months. The effects of hormones were examined by treating the animals with various agents during the latter half of the experimental period. Metabolic bal ance studies were performed during the last week of the experimental period, and at the end of the experimental period, the animals were killed, and blood and bone were obtained. Table 1 shows the effect of ovariectomy and low Ca diet on body weight gain and food ef fi ciency. Ovariectomy enhanced body weight gain and food efficiency, without affecting food intake of the animals. Low Ca diet itself did not affect these parameters significantly, in either sham operated or ovariectomized rats ( Table 1 ). As shown in Table 2 , although OVX rats on a nor mal Ca diet (0.47% Ca) showed a significant re duction in bone Ca content compared to sham operated rats, the effect of ovariectomy was more pronounced when the rats were fed a low Ca diet. Thus, in rats on a low Ca diet, ovariectomy caused a significant reduction in both Ca and P contents, as well as the breaking force of the femoral bone. Therefore, the effects of various hormones on these parameters were examined using OVX, Ca deficient rats.
Effect of calcitonin Circulating levels of immunoreactive calcito nin(CT) are reported to be low in patients with postmenopausal osteoporosis (1, 5) . Because CT has been shown to inhibit osteoclastic bone resorp tion (6) and to stimulate 1, 25(OH)2D3 synthesis (7), the reduction in CT levels may cause an en hancement of bone resorption and a reduction in intestinal Ca absorption. In order to clarify if CT has any preventive role on the development a The measurements were performed on the last day of the experimental period . b Significantly different from the sham-operated rats on the same diet (p<0.05). c Significantly different from the sham-operated rats on the same diet (p<0.01). Table 2 . Effect of ovariectomy and low calcium diet on serum levels of calcium and phosphorus , mineral con tents and physical properties of femoral bone in rats.
a Significantly different from the rats on normal Ca diet (p<0 .01). b Significantly different from the rats on nor mal Ca diet (p<0.05). c Significantly different from sham-operated rats on the same diet (p<0 .01).
of postmenopausal osteoporosis, the effect of CT on mineral metabolism and physical properties of bone were examined in OVX, Ca-deficient rats. Synthetic [Asu 1, 7] eel calcitonin (Togo Jozo Co., Shizuoka, Japan), 5 mU/100 g of P. W., was injected intramuscularly every day during the last month of the experimental period. As shown in Fig. 1 , CT treatment increased Ca content, as well as the breaking force of the femoral bone: There were no significant changes in serum levels of Ca or Pi with the CT treatment.
Physiological importance of CT has been stressed in relation to the postprandial handling of Ca, especially with the demonstration that plasma CT levels increase after feeding (8). Talmage and Van der Wiel (9) reported a marked increase in postprandial urinary Ca excretion, when the rats were thyroidectomized.
These results suggested that the physiological importance of the function of CT is to aid the transfer and storage of dietary Ca into bones. In addition, our recent observa tions indicate that CT enhances renal tubular re absorption of Ca in thyroparathyroidectomized rats (10) . Thus, CT may be playing an important role in the conservation of body Ca storage, and the maintenance of positive Ca balance by in hibiting bone resorption as well as stimulating 1, 25(OH)2D3 production and renal tubular Ca re absorption.
The present observations that CT treatment partly prevented the reduction in bone mineral contents and the physical tolerance of femur in OVX, Ca-deficient rats further support the above possibilities, and suggest that CT is effective for the treatment of postmenopausal oste 
Summary
A rat model of postmenopausal osteoporosis was introduced, using ovariectomized rats on a low Ca diet. CT treatment of these animals for one month prevented the decrease in both mineral contents and physical properties of the femoral bone. Treatment of the animals with 1, 25(OH)2D3 was effective in increasing bone mineral contents and maintaining positive mineral balance, but did not increase the physical tolerance of bones. In contrast, 24, 25(OH)2D3 increased the breaking force of the femoral bone, with minimal effect on bone mineral contents and mineral balance. These results suggest that 1, 25(OH)2D3 and 24, 25(OH)2D3 act differently on the matrix phase and mineral phase of bones, but that they act together to main tain mineral balance and structural integrity of bones. The mechanism of how these vitamin D metabolites affect bone metabolism remain to be clarified. 
